Navigation Links
ID, HIV experts urge more resources for TB

In honor of World TB Day 2008 (March 24), the Infectious Diseases Society of America (IDSA) and the HIVMA Medicine Association (HIVMA) are urging U.S. policymakers to step up the fight against tuberculosis by committing substantial resources against the disease both at home and abroad.

With drug-resistant strains of TB on the rise and progress in detecting new cases on the decline, resources are needed to support TB care, surveillance, infection control, and research into new drugs, diagnostics, and vaccines.

The standard test for diagnosing TB is more than 100 years old and it fails to adequately detect the disease in children and people with HIV. The newest class of TB drugs is more than 40 years old and does a poor job on drug-resistant TB. Todays TB vaccine is more than 85 years old and is not highly effective, and for that reason it is not recommended for routine use in the United States, said Carol Dukes Hamilton, MD, an IDSA and HIVMA spokesperson who works on TB and HIV in the United States and the developing world.

TB remains one of the leading infectious disease killers worldwide, with about 9 million new cases and almost 2 million deaths each year. In the U.S. alone, about 10 million to 14 million people are estimated to be infected with latent tuberculosis. Active TB can be easily passed to otherseven healthy adults and childrensimply by breathing the same air. The World Health Organization estimates that nearly half a million cases of TB are resistant to first-line drugs.

In the developing world, TB is the leading killer of people with HIV. The two epidemics fuel each other in a vicious cycle. People with HIV are more susceptible to getting sick and dying from TB if they are exposed, and TB bacteria accelerate the progression of HIV to AIDS. Absent a comprehensive plan to control tuberculosis, this deadly infection threatens to undermine the gains that have been made in saving the lives of persons living with HIV in the developing world.

Legislation in both the House and Senate would devote substantial resources$4 billion over five yearsto stopping TB in the developing world through the Presidents Plan for AIDS Relief (PEPFAR). PEPFAR supports HIV/AIDS programs in 15 countries that comprise 21 percent of the global TB burden and 24 percent of the worlds annual TB deaths. The program offers millions more in support of HIV prevention and treatment activities in scores of other developing countries.

The U.S. government has been a leader in stopping HIV/AIDS in the developing world, said Dr. Hamilton. We must show the same bold leadership on tuberculosis; otherwise, we run the risk of losing ground on control of tuberculosisincluding highly drug-resistant TBand HIV/AIDS.

Unfortunately, the Bush administrations proposed budget for fiscal year 2009 includes significant cuts for TB and other infectious disease programs. Especially hard-hit is the U.S. Centers for Disease Control and Prevention (CDC), which would see a cut of nearly half a billion dollars in its total budget. IDSA supports increasing CDCs overall budget by 15 percent and devoting $300 million for efforts to prevent, control, and eliminate tuberculosis in the United States. Likewise, IDSA supports increased resources for the National Institutes of Health (NIH)s TB programs. NIH expects to spends about $187 million on TB in fiscal year 2009, including $17 million on efforts to find a new vaccine.


Contact: Steve Baragona
Infectious Diseases Society of America

Related medicine news :

1. CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
2. New England Area Fertility Experts Issue Call for Ethnic Egg Donors
3. Experts call for community mobilization to curb youth violence
4. The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal
5. Experts will analyze the nutrition and health relationship from pregnancy to adolescence
6. Spiritual Health Experts Speak at Chaplains Conference in Pittsburgh March 8-12
7. Experts Delve Into Issues of HPV Vaccination
8. MEDIA ADVISORY: New York Lt. Gov. David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit
9. Flu Season at Its Peak: Experts Have Tips for Staying Healthy
10. Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010
11. Key Business, Labor and Academic Experts Join Stop Obesity Alliance Panel to Present Policy Perspectives and Recommendations to Reshape The Union
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: